Skip to main content
Log in

Selective depletion of the allo-antigen specific T cells by Fas/FasL pathway by cytokine IFN-γ and IL-2

  • Published:
Current Medical Science Aims and scope Submit manuscript

Summary

To investigate the value of apoptosis of the allo-antigen specific T cells induced by Fas/FasL pathway in preventing graft-versus-host disease (GVHD), the CD34+ cells transfected with FasL or not, used as stimulus cells, were mixed with allo-antigen specific T lymphocytes in presence or absence of IFN-γ and IL-2. After 5 days, apoptosis of T cells was detected by TdT nick end mediated dUTP labeling (TUNEL) and flow cytometry (FCM). The affects of these two cytokines on CD34+ cells in the graft were also compared. The ratio of apoptosis of T cells was 12.1±1.5% when CD34+ cells transfected with FasL was used as stimulus cells, much higher than that of CD34+ cells non-transfected (3.2±1.1%,P<0.01). And in presence of IFN-γ or IL-2, the ratio reached 20.1±2.3%, 17.6±1.3% respectively (P<0.01). However, IFN-γ up-regulated Fas expression of CD34+ cells and increased the sensibility of CD34+ cells to soluble FasL(sFasL); IL-2 showed no such affect. It is possible to induce apoptosis of the allo-antigen specific T cells of grafts activated by allo-antigen by exogenous Fas ligand expressed on recipient cells and this might provide a new approach for preventing GVHD and IL-2 may be more suitable for clinical application.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kataoka Y, Iwasaki T, Kuroiwa Tet al. The role of donor T cells for target organ injuries in acute and chronic graft-versus-host disease. Immunology, 2001, 103: 310

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Champlin R. T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation. Hematol Oncol Clin North Am, 1990, 4: 687

    Article  CAS  PubMed  Google Scholar 

  3. Connell J, Sullivan G C, Collins J Ket al. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand. J Exp Med, 1996, 184: 1075

    Article  Google Scholar 

  4. Lau H T, Yu M, Fontana Aet al. Prevetion of islet allograft rejection with engineered myoblasts expressing FasL in mice. Science, 1996, 273: 109

    Article  ADS  CAS  PubMed  Google Scholar 

  5. van den Brink M R, Moore E, Horndasch KJet al. Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease. Transplantation, 2000, 70: 184

    PubMed  Google Scholar 

  6. Deeg H J. Cytokines in graft-versus-host disease and the graft-versus-leukemia reaction. Int J Hematol, 2001, 74(1):26

    Article  CAS  PubMed  Google Scholar 

  7. Deeg H J, Beckham C, Loken M Ret al. Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome. Leuk Lymphoma, 2000, 37: 405

    Article  CAS  PubMed  Google Scholar 

  8. Stahnke K, Hecker S, Kohne Eet al. CD95 (APO-1/FAS)-mediated apoptosis in cytokine-activated hematopoietic cells. Exp Hematol, 1998, 26: 844

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

XIAO Juan, female, born in 1974, MD

This project was supported by the grant from National Natural Science Foundation of China (No. 39770767).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Juan, X., Ping, Z., Zhongwen, L. et al. Selective depletion of the allo-antigen specific T cells by Fas/FasL pathway by cytokine IFN-γ and IL-2. Current Medical Science 23, 344–347 (2003). https://doi.org/10.1007/BF02829413

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02829413

Key words

Navigation